top of page

Pfizer's first DiGA launch: App on prescription against chronic pain

Updated: May 28

Pfizer is supporting the company Selfapy in the market launch and marketing of the app "Selfapy's Online Course for Chronic Pain": On April 18, the digital health application (DiGA) was approved by the BfArM and included as a certified medical device in the provisional DiGA directory of the BfArM.


Cooperation with Selfapy: Pfizer's first DiGA launch: App on prescription against chronic pain | Pfizer Healthcare Hub








bottom of page